(Q40395689)

20 September 2017

1 reference

title

New anticoagulant strategies. Current status and future potential (English)

1 reference

20 September 2017

1 reference

1 reference

J Weitz

1

1 reference

20 September 2017

publication date

1 October 1994

1 reference

20 September 2017

1 reference

20 September 2017

volume

48

1 reference

20 September 2017

issue

4

1 reference

20 September 2017

page(s)

485-497

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199448040-00001

20 September 2017

exact match

0 references

cites work

The structure of a complex of recombinant hirudin and human alpha-thrombin

1 reference

12 December 2020

Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris

1 reference

12 December 2020

Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin

1 reference

12 December 2020

Intravenous and endobronchial administration of G4120, a cyclic Arg-Gly-Asp-containing platelet GPIIb/IIIa receptor-blocking pentapeptide, enhances and sustains coronary arterial thrombolysis with rt-PA in a canine preparation

1 reference

12 December 2020

The effect of thrombin inhibitors on tissue plasminogen activator induced thrombolysis in a rat model

1 reference

12 December 2020

Domains specifying thrombin–receptor interaction

1 reference

12 December 2020

Initial experience with a direct antithrombin, Hirulog, in unstable angina. Anticoagulant, antithrombotic, and clinical effects

1 reference

12 December 2020

Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial

1 reference

12 December 2020

Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy.

1 reference

12 December 2020

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

12 December 2020

Hirudin and derivatives as anticoagulant agents

1 reference

12 December 2020

Antithrombins: their potential as antithrombotic agents

1 reference

12 December 2020

Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin

1 reference

12 December 2020

Thrombin activity of fibrin thrombi and soluble plasmic derivatives

1 reference

12 December 2020

Disintegrins: a family of integrin inhibitory proteins from viper venoms

1 reference

12 December 2020

A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex

1 reference

12 December 2020

Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot Study

1 reference

12 December 2020

Anticoagulant activity of synthetic hirudin peptides

1 reference

12 December 2020

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors

1 reference

12 December 2020

A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction

1 reference

12 December 2020

Hirulog peptides with scissile bond replacements resistant to thrombin cleavage.

1 reference

12 December 2020

Platelets and thrombolytic therapy

1 reference

12 December 2020

Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs

1 reference

12 December 2020

Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial

1 reference

12 December 2020

Safety and antiplatelet effect of murine monoclonal antibody 7E3 Fab directed against platelet glycoprotein IIb/IIIa in patients undergoing elective coronary angioplasty

1 reference

12 December 2020

Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty

1 reference

12 December 2020

Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor

1 reference

12 December 2020

Adjuncts to thrombolysis for myocardial reperfusion

1 reference

12 December 2020

Heparin-induced prolongation of partial thromboplastin time after thrombolysis: Relation to coronary artery patency

1 reference

12 December 2020

Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis

1 reference

12 December 2020

New perspectives in cell adhesion: RGD and integrins

1 reference

12 December 2020

1 reference

12 December 2020

Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation

1 reference

12 December 2020

Low molecular weight heparin

1 reference

12 December 2020

Binding of thrombin to subendothelial extracellular matrix. Protection and expression of functional properties

1 reference

12 December 2020

10.2165/00003495-199448040-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

1029376103

0 references

1 reference